Navigation Links
Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results
Date:11/9/2007

SAN DIEGO, Nov. 9 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today announced that it will release its third quarter ended September 30, 2007 financial results after the close of market on Wednesday, November 14, 2007.

Cadence management will host a conference call and live webcast to discuss the financial results and provide a corporate overview on Thursday, November 15, 2007 at 8:30 am Eastern Time (5:30 am Pacific Time). Interested investors may participate in the conference call by dialing 800-289-0461 (domestic) or 913-312-6680 (international). To access the webcast, please log on to the company's website at http://www.cadencepharm.com and go to the Investor Relations page. A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, including intravenous acetaminophen (IV acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% aqueous gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit http://w
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
2. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIO Investor Forum
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
11. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...URE: HTL , TORONTO, Nov. 24 /PRNewswire-First...y Calotto Capital Inc., a leading provider of adva...ll research and fertility clinic markets, today re...hird quarter ended September 30, 2009. , , Q3 ... compared with $1.43 million in Q3 2008, - Gr...
(Date:11/24/2009)...IEGO, Nov. 24, 2009 Aren... today that the company is scheduled to present ...rence on December 1, 2009 at 11:30 a.m. Eastern Ti... Hotel in New York City. Jack Lief, Arena,s Presid...rovide an overview of the company, including its c...
(Date:11/24/2009)...ZEN, Italy, November 24 Health Rob...adian joint venture with a group of selected,inves...ill operate under the,name Health Robotics Canada,... Robotics, i.v. Room of the Future concept, which ...TATION(TM), i.v.SOFT(TM), and OMM(TM).,Health Robo...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the global ...,s patent office is now the world,s leading produc...China trailed Japan,s patent office, the World Int...ited States Patent and Trademark Office (USPTO) fo..., WIPO in 2006, and exceeded Japan for the first t...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
... March 26 On March 23, 2009 the,United States Pat...nal Action,Closing Prosecution in the ongoing re-e...t Number 6,543,447. Aircraft Medical, Ltd. filed t...n 2006 following litigation (currently on,hold) th...new Action from the USPTO has rejected 393 claims ...
...Manufacturing Drives Aggressive Conversion Program... leading provider of cell culture materials and se...e biopharmaceutical industry and a business segmen...oup (Nasdaq: SIAL ), today announced it has comp...e media continuous milling production site in Lene...
... MacroGenics, Inc., a privately held biotechnolog...t autoimmune disorders, cancer and infectious dise...er as Vice President, Business Development. "I am...other exceptionally talented professional to the m...nig, President and CEO. "Eric has spent the last ...
Other Biology Technology:US Patent Office Rejects 95% of Verathon Claims in Patent Case With Aircraft Medical 2SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 2SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 3SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 4MacroGenics Appoints New Vice President of Business Development 2MacroGenics Appoints New Vice President of Business Development 3
(Date:11/24/2009)... This release is available in Spanish . ,... higher levels of inflammatory substances in the b...ght; as shown by a research project of the Univers...to, a scientist at the School of Pharmacy. , The...c study in relation to the control of body weight ...
(Date:11/23/2009)... Washington, D.C. The community-associated strai...bacteria resistant to most common antibioticsposes... and is making its way into hospitals, according t...tious Diseases . , The new threat is easily pic...ic places and has increased the overall burden of ...
(Date:11/23/2009)..., TORONTO, November 23, 2009 - The time of day m...ding to a new paper produced by a research team le...onto Scarborough,s vice-principal for research and...biology at the St. George campus. , Capitalizi...the poplar tree, the research team examined how po...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2America 26apos 3Bs Organic Home Fueling Movement Begins in Los Angeles 13316 1America 26apos 3Bs Organic Home Fueling Movement Begins in Los Angeles 13316 2America 26apos 3Bs Organic Home Fueling Movement Begins in Los Angeles 13316 3Fastrack Release First Integrated HME Billing Infusion Pharmacy 26amp 3B Home Care Agency Software in a Microsoft Environment 53415 1Fastrack Release First Integrated HME Billing Infusion Pharmacy 26amp 3B Home Care Agency Software in a Microsoft Environment 53415 2Play it Straight with Swine Flu AA Travel Insurance Advises 53412 1Play it Straight with Swine Flu AA Travel Insurance Advises 53412 2Play it Straight with Swine Flu AA Travel Insurance Advises 53412 3Play it Straight with Swine Flu AA Travel Insurance Advises 53412 4
...ransform a key component of disposable cups, plate... significantly reducing the environmental impact o...stream, according to a study scheduled to appear i...ty journal, Environmental Science & Technolog...acterium Pseudomonas putida, converted polystyrene...
...ity of Pittsburgh Professor of Anthropology Jeffre...of Biochemistry Bruno Maresca, published Jan. 30 i...ng understanding of cell structure lends strong su...y explained in his seminal work, Sudden Origins: F...Wiley & Sons, 2000). , In that book, Schwartz ...
...in less than 0.2% of the 3-billion-base human geno...uman disease. Today, researchers from the Wellcome...ty,s Cambridge Institute for Medical Research, tog... Genetics their detailed maps of differences impli...ed in recent human history. , The Major Histocomp...
Other Biology News:Microbes convert 'Styrofoam? into biodegradable plastic 2Pitt professor's theory of evolution gets boost from cell research 2Pitt professor's theory of evolution gets boost from cell research 3Researchers map of genetic variations implicated in disease 2Researchers map of genetic variations implicated in disease 3
...uaMax DW4 liquid handling system from Molecular De...hing all in one instrument. The system handles a v...ashing96-, 384- and 1536-welland is the first to h...s been optimized to dispense from four different c...
Horizontal Laminar Flow Work Station from Terra Universal, Inc.
... series embodies all aspects of classical microsco...l Achromatic Super Contrast (ASC) objectives coupl...p, this microscope combines flexibility and profes...popular B1 series, the DM-B1 steps into the 21st c...
...ermo Sequenase Dye Primer Manual Cycle Sequencing ...beled primers and high-resolution fluorescence sca...step followed by standard slab gel electrophoresis...agged sequencing products. The kit components hav...
Biology Products: